Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pooled UCB Transplant for Hematologic Malignancies
NCT01500161Phase 2Terminated
- Sponsor
- Texas Oncology
- Start
- Nov 2011
- Primary completion
- Nov 2013
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), Hodgkin lymphoma (HL), sponsored by Texas Oncology. Started Nov 2011; status: terminated.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic lymphocytic leukemia (CLL)chronic myeloid leukemia (CML)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01500161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01500161.